Kronos Bio, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Kronos Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Kronos Bio, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$18M, a 44% increase year-over-year.
  • Kronos Bio, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$111M, a 13.1% increase year-over-year.
  • Kronos Bio, Inc. annual Operating Income (Loss) for 2023 was -$122M, a 11.1% increase from 2022.
  • Kronos Bio, Inc. annual Operating Income (Loss) for 2022 was -$137M, a 9.43% increase from 2021.
  • Kronos Bio, Inc. annual Operating Income (Loss) for 2021 was -$151M, a 161% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$122M +$15.3M +11.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$137M +$14.3M +9.43% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$151M -$93.4M -161% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 -$58M -$41.2M -245% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 -$16.8M -$10.2M -153% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$6.65M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.